Randomized Double-Blind Phase II Study of Regorafenib in Patients With Metastatic Osteosarcoma.
J Clin Oncol. 2019 Jun 1;37(16):1424-1431. doi: 10.1200/JCO.18.02374. Epub 2019 Apr 23.
J Clin Oncol. 2019.
PMID: 31013172
Free PMC article.
Clinical Trial.